US Patent 6630507 - Cannabinoids as antioxidants and neuroprotectants
The United States of America, as represented by the Department of Health and Human Services, has obtained patents on various compounds that come from marijuana.
One substance in marijuana that does not have any mind-altering effects may be useful for protecting the brain from the damaging effects of stroke and disease.
Scientists at the National Institute of Mental Health found that cannabidiol appears to protect the brain cells of rats in experiments in the laboratory, according to a report in the July 7 issue of the Proceedings of the National Academy of Sciences.
US Patent 6630507 - Cannabinoids as antioxidants and neuroprotectants can be found by researching the US Patent records.
The Owner/Assignee of the patent is the Department of Health and Human Services. Specifically named is Dr. Aidan J Hampson from the National Institutes of Health.
Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and HIV dementia.
One substance in marijuana that does not have any mind-altering effects may be useful for protecting the brain from the damaging effects of stroke and disease.
Scientists at the National Institute of Mental Health found that cannabidiol appears to protect the brain cells of rats in experiments in the laboratory, according to a report in the July 7 issue of the Proceedings of the National Academy of Sciences.
US Patent 6630507 - Cannabinoids as antioxidants and neuroprotectants can be found by researching the US Patent records.
The Owner/Assignee of the patent is the Department of Health and Human Services. Specifically named is Dr. Aidan J Hampson from the National Institutes of Health.
Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and HIV dementia.
0 Comments:
Post a Comment
<< Home